Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Y-mAbs Therapeutics Inc (YMAB)

  • Technical Exchange News
  • Sept. 17, 2025, 00:59 UTC
  • 20
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Y-mAbs Therapeutics, Inc. - Common Stock.

Comment Full text

Y-mAbs Therapeutics Inc (YMAB)

  • Technical Exchange News
  • Sept. 17, 2025, 00:59 UTC
  • 20
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Y-mAbs Therapeutics, Inc. - Common Stock.

Comment Full text

TNF Pharmaceuticals, Inc. (TNFA)

  • Technical Exchange News
  • Sept. 16, 2025, 18:49 UTC
  • 20
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Shattuck Labs Inc (STTK)

  • Technical Exchange News
  • Sept. 16, 2025, 18:49 UTC
  • 18
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Heart Test Laboratories Inc (HSCS)

  • Technical Exchange News
  • Sept. 16, 2025, 18:48 UTC
  • 18
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Heart Test Laboratories Inc (HSCSW)

  • Technical Exchange News
  • Sept. 16, 2025, 18:48 UTC
  • 16
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Talkmed Group Limited (5G3)

  • Technical Exchange News
  • Sept. 16, 2025, 16:23 UTC
  • 14
  • 0 comments

SGX symbol attribute type Security_Name was changed. Previous value: -. New value: TalkMed.

Comment Full text

CAN B CORP. (CANB)

  • Technical Exchange News
  • Sept. 16, 2025, 10:20 UTC
  • 15
  • 0 comments

Grey symbol attribute type Security_Name was changed. Previous value: POWER FINL CP PFD D. New value: CAN B CORP.

Comment Full text

Relmada Therapeutics Inc (RLMD)

  • Technical Exchange News
  • Sept. 16, 2025, 01:59 UTC
  • 15
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Relmada Therapeutics Inc (RLMD)

  • Technical Exchange News
  • Sept. 15, 2025, 19:35 UTC
  • 18
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next

Search

News categories

  • Technical Exchange News(10266)
  • Event(1436)
  • SEC News(174176)
  • FDA Approval(9605)
  • Company Report(721)
  • Business News(116933)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin